Search
for
Sort by
Research 421–450 of 1000+
- A decade of progress in androgenetic alopecia management: Emerging therapies and multimodal strategies
- Evidence for the off-label use of tofacitinib in alopecia areata
- Transforming growth factor-β in stem cells and tissue homeostasis
- Treatment of frontal fibrosing alopecia: literature review 2020-2025
- Active Compounds with Medicinal Potential Found in Maxillariinae Benth. (Orchidaceae Juss.) Representatives—A Review
- How Long to Treat to Achieve Desired Treatment Outcomes with Baricitinib 4 mg in Severe Alopecia Areata: Evidence-based Approach
- Efficacy, safety and dose response of STS01, a topical controlled release nanoparticle formulation (dithranol/Prosilic), in adults with mild to moderate patchy alopecia areata: A randomised, double-blind, multicentre, phase 2 trial
- Comparison of the Treatment Outcome of Oral Tofacitinib with Other Conventional Therapies in Refractory Alopecia Totalis and Universalis: A Retrospective Study
- Experience with oral tofacitinib in two adolescents and seven adults with alopecia areata
- Anticytokine therapy, particularly anti-IFN-γ, in Th1-mediated autoimmune diseases
- Genome-wide meta-analysis identifies novel loci conferring risk of acne vulgaris
- Interconnected PolymerS TeChnology (IPSTiC): An Effective Approach for the Modulation of 5α-Reductase Activity in Hair Loss Conditions
- Telogen Effluvium after SARS-CoV-2 Infection: A Series of Cases and Possible Pathogenetic Mechanisms
- Follikelhormone
- Comparative efficacy and safety of JAK inhibitors in the treatment of moderate-to-severe alopecia areata: a systematic review and network meta-analysis
- Ginsenoside CK inhibits androgenetic alopecia by regulating Wnt/β‐catenin and p53 signaling pathways in AGA mice
- 5α-reductase inhibitors impact prognosis of urothelial carcinoma
- MicroRNA-214 controls skin and hair follicle development by modulating the activity of the Wnt pathway
- Tofacitinib (Selective Janus Kinase Inhibitor 1 and 3): A promising therapy for the treatment of alopecia areata: A case report of six patients
- Role of janus kinase inhibitors in the treatment of alopecia areata
- Safety of Tyrosine Kinase Inhibitors in Patients With Differentiated Thyroid Cancer: Real-World Use of Lenvatinib and Sorafenib in Korea
- Evaluation of the efficacy and treatment-emergent adverse events of deuruxolitinib for moderate to severe alopecia areata: a dose-ranging meta-analysis of 1,372 randomized patients
- Cutaneous manifestations associated with immune checkpoint inhibitors
- Wound healing with topical BRAF inhibitor therapy in a diabetic model suggests tissue regenerative effects
- Adverse events in patients treated with Jak‐inhibitors for alopecia areata: A systematic review
- Evaluating Current and Emergent JAK Inhibitors for Alopecia Areata: A Narrative Review
- PENAPISAN SENYAWA DARI REMPAH-REMPAH KHAS INDONESIA TERHADAP MMP9 DAN TNFα SEBAGAI TARGET PENYEMBUHAN LUKA DIABETES DENGAN METODE PENAMBATAN MOLEKUL
- Efficacy and safety of tofacitinib in pediatric patients with alopecia areata: A prospective cohort study
- Hidradenitis Suppurativa/Acne Inversa/Dissecting Terminal Hair Folliculitis
- Clinical and Histopathological Features and Potential Pathological Mechanisms of Skin Lesions in COVID-19: Review of the Literature